Ligand Pharmaceuticals Incorporated (LGND)

Handelsbanken Fonder AB Raises Stake in Ligand Pharmaceuticals Incorporated $LGND

Ligand Pharmaceuticals Q2 Earnings Call Highlights

Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Arrowstreet Capital Limited Partnership

Ashford Capital Management Inc. Has $41.44 Million Holdings in Ligand Pharmaceuticals Incorporated $LGND

Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gilead Sciences, Goldman Sachs, Microsoft, Salesforce, and More

Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

XOMA Royalty Announces Closing of Its Acquisition by Ligand

5 Stock Setups Where Wall Street Sees the Most Upside Right Now

Ligand Pharma: Expect Bright And Exciting Future For This Growing Royalty Aggregator

Ligand Announces Closing of Convertible Senior Notes Offering

Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

Ligand Pharmaceuticals Director Unloads 2,501 Shares — Should You Be Concerned?

Ligand Announces 2026 Investor Day in New York City

A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million

Ligand to Participate in June Investor Conferences

Saying Goodbye To The XOMA Royalty PFDs